Fungus-derived antibacterial blue fluorescent carbon dots as well as preparation method and application thereof

Positively charged blue fluorescent carbon dots Du-CDs prepared by the extract of C. phytosus cerevisiae solves the problems of poor water solubility and insufficient biocompatibility of existing antibacterial nanomaterials, and achieves efficient bactericidal and sterilization of various microorganisms and Wound heals, with good biosafety and stability.

CN119020028AActive Publication Date: 2024-11-26SOUTHEAST UNIV
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411131507.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-18
Publication Date
2024-11-26
Estimated Expiration
2044-08-18

AI Technical Summary

Technical Problem

The existing antibacterial nanomaterials have problems such as poor water solubility, dissatisfaction with biocompatibility, lack of antifungal activity, and the antibacterial compounds extracted from fungi have high toxicity, limited stability and general antibacterial properties.

Method used

The extract of C. Chrysanthesia is used to synthesize positively charged blue fluorescent carbon dots Du-CDs by heating, and the preparation process is performed by ethyl acetate extraction and solvothermal method to form nanomaterials with high efficiency antibacterial and good biocompatibility.

Benefits of technology

The broad-spectrum antibacterial properties against Gram-positive bacteria, Gram-negative bacteria and fungi were achieved, which significantly improved the antibacterial effect and wound healing ability, and had good biosafety and long-term preservation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020028A_ABST
    Figure CN119020028A_ABST
Patent Text Reader

Abstract

The invention discloses a fungus-sourced antibacterial blue fluorescent carbon dot and a preparation method and application thereof.According to the carbon dot, the fluorescent carbon dot is synthesized by heating a raw material of an extract of Metalaria thunbergii, a natural product extract of endophyte YSP3 serves as a raw material, the blue fluorescent carbon dot Du-CDs is synthesized through a one-step solvothermal method, the average particle size of the Du-CDs is 13.9 nm, and the particle size of the Du-CDs is 13.9 nm. Positive charges are carried. The Du-CDs prepared by the invention can efficiently kill bacteria and fungi, and has broad-spectrum antibacterial performance. The invention provides the carbon dots which have better bactericidal effect and wound healing ability and good biological safety compared with natural fungus extracts, and a novel antibacterial drug with good fluorescence is developed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of nanomaterials and biotechnology, and particularly relates to antibacterial blue fluorescent carbon dots derived from fungi, and a preparation method and application thereof. Background Art

[0002] Microbial infections have long posed a serious threat to global human health, and antibiotics are currently the most widely used antimicrobial treatment. However, overuse of antibiotics has led to increased microbial resistance, necessitating the development of novel antimicrobial therapies. Studies have shown that nanomaterials possess both antibacterial and bactericidal properties. However, many antimicrobial nanomaterials suffer from shortcomings such as poor water solubility and poor biocompatibility, and most lack antifungal activity. Therefore, there is an urgent need to develop nanomaterials with broad-spectrum antimicrobial properties and good biocompatibility to address these issues.

[0003] Carbon dots (CDs), as a new type of zero-dimensional carbon-based fluorescent nanomaterial, have attracted increasing attention due to their outstanding properties and have become a research hotspot in recent years. Compared with other nanomaterials, CDs are easy to synthesize, have high water dispersibility, low toxicity, good biocompatibility and excellent photoluminescence properties. Because the surface contains different types of functional groups such as amino (-NH2), hydroxyl (-OH) and carboxyl (-COOH), CDs exhibit different electrical properties. Studies have shown that positively charged CDs can easily bind to and interact with negatively charged bacterial cell membranes through electrostatic interactions, killing bacteria by damaging the cell membrane.

[0004] Fungi are an important source of natural antimicrobial compounds. However, antimicrobial compounds extracted directly from fungi have disadvantages such as high toxicity, limited stability, difficulty in long-term storage, and general antimicrobial properties. Therefore, there is an urgent need to develop more efficient antimicrobial materials. Summary of the Invention

[0005] Purpose of the invention: In response to the problems existing in the prior art, the present invention proposes a fungal-derived antibacterial blue fluorescent carbon dot. The present invention utilizes fungal extracts to prepare highly efficient antibacterial fluorescent carbon dots, providing a new and flexible strategy for developing new antibacterial nanomaterials from natural production, and avoiding the shortcomings encountered in the process of discovering and developing antibacterial drugs from natural products, such as high toxicity, limited stability, difficulty in long-term storage, and general antibacterial performance.

[0006] The present invention also provides a preparation method and application of the fungus-derived antibacterial blue fluorescent carbon dots.

[0007] Technical solution: In order to achieve the above purpose, the present invention provides a fungus-derived antibacterial blue fluorescent carbon dot, which is synthesized by heating the extract of Aspergillus niger.

[0008] Wherein, the Diaporthe unshiuensis is Diaporthe unshiuensis YSP3.

[0009] Wherein, the extract is an ethyl acetate extract.

[0010] The method for preparing fungus-derived antibacterial blue fluorescent carbon dots of the present invention comprises the following steps:

[0011] (1) culturing the strain Aspergillus intermedius to obtain mycelium;

[0012] (2) Transfer the mycelium to potato dextrose medium and continue culturing;

[0013] (3) filtering the culture solution and extracting it with ethyl acetate to obtain an extract;

[0014] (4) heating the extract to obtain a solvent-free substance;

[0015] (5) The solvent-free substance was dissolved in deionized water to form a light yellow solution, which was then centrifuged at high speed and filtered to obtain an aqueous solution containing Du-CDs. The solution was dialyzed and freeze-dried to obtain blue carbon dots.

[0016] The culture conditions in step (1) are 25-30° C. for 3-7 days; and the culture conditions in step (2) are 20-30° C. for 1-5 days.

[0017] Preferably, in step (1), strain YSP3 is cultured on a PDA plate at 28° C. for 5 days; and in step (2), the mycelium is transferred from the plate to a potato dextrose medium and cultured at 25° C. and 150 rpm for 3 days.

[0018] Wherein, in step (3), the culture solution is filtered through filter paper and then extracted 2-3 times with an equal volume of ethyl acetate.

[0019] Preferably, step (3) uses 185 mm Whatman 1 filter paper, and during extraction, ethyl acetate, i.e., 200 mL, is added in an equal volume ratio, and extraction is performed twice.

[0020] In step (4), the extract is transferred to a stainless steel autoclave and heated at 120-240° C. for 6-18 hours to obtain a solvent-free substance.

[0021] Preferably, in step (4), the extract is transferred to a stainless steel autoclave and heated at 180° C. for 12 h to obtain a solvent-free substance.

[0022] Furthermore, the stainless steel autoclave is a stainless steel high-temperature autoclave lined with polytetrafluoroethylene.

[0023] Preferably, (5) the solid substance is dissolved in deionized water to form a light yellow solution, which is centrifuged at high speed and filtered with a 0.22 μm filter to obtain an aqueous solution containing Du-CDs.

[0024] Furthermore, the centrifugal speed in step (5) is 12000 rpm, and the filtrate obtained by filtration is dialyzed with Milli-Q water for 6-18 hours and freeze-dried to obtain fluorescent carbon dots Du-CDs.

[0025] The invention relates to the use of the fungus-derived antibacterial blue fluorescent carbon dots in the preparation of in vivo and in vitro antibacterial drugs or reagents.

[0026] Among them, the antibacterial microorganisms include Gram-positive bacteria, Gram-negative bacteria and fungi; the Gram-positive bacteria include Escherichia coli, Proteus, and Serratia marcescens; the Gram-negative bacteria include Staphylococcus aureus, Staphylococcus epidermidis, and Micrococcus luteus; the fungi include Saccharomyces cerevisiae and Candida albicans.

[0027] The invention relates to the use of the fungus-derived antibacterial blue fluorescent carbon dots in the preparation of a medicine with wound healing ability.

[0028] The present invention uses Diaporthe unshiuensis YSP3 as raw material and a natural product extract of the endophytic fungus YSP3 as raw material, and synthesizes blue fluorescent carbon dots Du-CDs using a one-step solvothermal method. The Du-CDs have an average particle size of 13.9 nm and are positively charged. Du-CDs can effectively kill bacteria and fungi and have broad-spectrum antimicrobial properties. The present invention provides carbon dots that have better bactericidal efficacy, wound healing ability, and good biosafety than natural fungal extracts, and develops a new antibacterial drug with good fluorescence. The Du-CDs prepared by the present invention can be stored for a long time compared to fungal extracts and have better drug resistance than traditional antibiotics.

[0029] In this study, positively charged blue fluorescent carbon dots (Du-CDs) were successfully synthesized via a solvothermal method using an ethyl acetate extract of the culture medium of the fungus YSP3. Du-CDs exhibited significantly improved antibacterial activity against bacteria (Gram-negative and Gram-positive) and fungi compared to fungal extracts. Du-CDs demonstrated enhanced antibacterial activity and wound healing abilities in a mouse model and exhibited good biocompatibility. The specific nanomaterials prepared in this study possess unique properties due to their size, shape, charge, stability, and surface area, enabling them to more rapidly penetrate pathogenic bacteria, disrupting cellular contents and leading to bacterial death.

[0030] Beneficial effects: Compared with the prior art, the present invention has the following advantages:

[0031] The preparation process of the blue fluorescent carbon dots Du-CDs prepared by the present invention is simple, rapid, cost-effective, and environmentally friendly. Compared with the extract of Aspergillus YSP3, Du-CDs exhibit superior antibacterial and antifungal efficacy and accelerated wound healing. Furthermore, Du-CDs exhibit excellent biocompatibility. This invention provides a new and flexible strategy for developing novel antibacterial nanomaterials from natural products, circumventing the shortcomings encountered in the discovery and development of antibacterial drugs from natural products. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 Transmission electron microscopy images of Du-CDs;

[0033] Figure 2 is the zeta potential of Du-CDs;

[0034] Figure 3 is the UV-visible absorption spectrum of Du-CDs;

[0035] Figure 4 is the fluorescence spectrum of Du-CDs;

[0036] Figure 5 For the antibacterial evaluation of Du-CDs;

[0037] Figure 6 To evaluate the time-dependent antibacterial activity of Du-CDs;

[0038] Figure 7 To evaluate the in vivo antibacterial effect and wound healing of Du-CDs;

[0039] Figure 8 Evaluation of hemolytic activity of Du-CDs.

[0040] In the figures, ** represents statistically p < 0.01, and *** represents statistically p < 0.001. DETAILED DESCRIPTION

[0041] The present invention will be further described below with reference to the accompanying drawings and examples.

[0042] Unless otherwise specified, the materials and reagents used in the following examples are all commercially available. Experimental methods without specific conditions specified in the examples are generally performed under conventional conditions or the conditions recommended by the manufacturer.

[0043] The Diaporthe unshiuensis YSP3 in the present invention is a well-known strain in the prior art; Chemical Investigation of Endophytic Diaporthe unshiuensis YSP3 Reveals New Antibacterial and Cytotoxic Agents, JOURNAL OF FUNGI, 2023, 9(2). Provided by Southeast University.

[0044] The other strains were all commonly used wild-type strains.

[0045] Example 1

[0046] Preparation of Du-CDs

[0047] Strain YSP3 was inoculated onto PDA plates and cultured at 28°C for 5 days. After 5 days of culture, when mycelium had just covered the plate, the entire plate was transferred to 200 mL of potato dextrose broth and incubated at 25°C and 150 rpm for 3 days. The culture broth was filtered through 185 mm Whatman 1 filter paper and thoroughly extracted with an equal volume of ethyl acetate (2 x 200 mL). The organic phases extracted with ethyl acetate were combined and transferred to a Teflon-lined stainless steel autoclave, heated at 180°C for 12 hours to obtain a solvent-free solid. The solid was dissolved in deionized water and centrifuged at 12,000 rpm for 10 minutes to obtain the supernatant, which was filtered through a 0.22 μm filter to obtain an aqueous solution containing Du-CDs. The resulting Du-CDs aqueous solution was further dialyzed using a 1000 Da dialysis bag containing ultrapure water for 12 hours at room temperature. The dialyzed solution was lyophilized to obtain Du-CDs blue fluorescent carbon dots and stored at 4°C until further use.

[0048] Example 2

[0049] 1. Morphological observation of Du-CDs

[0050] The Du-CDs fluorescent carbon dots prepared in Example 1 were redissolved and diluted with deionized water, 10 μL of which was dropped on a copper grid and observed using a transmission electron microscope (TEM, JEM-2100, JEOL Ltd., Japan). Figure 1 Transmission electron microscopy results show that the fluorescent carbon dots are graphite or amorphous, with an average particle size of about 13.9 nm.

[0051] 2. Zeta potential of Du-CDs

[0052] The zeta potential of the Du-CDs prepared in Example 1 was measured using a Zetasizer (Malvern Instruments, Nano ZS, United Kingdom). Figure 2 As shown, the surface charge of Du-CDs is 9.2 ± 0.6 mV, indicating that Du-CDs have supercationic properties.

[0053] 3. Zeta potential of Du-CDs

[0054] The zeta potential of the Du-CDs prepared in Example 1 was measured using a Zetasizer (Malvern Instruments, Nano ZS, United Kingdom). Figure 2 As shown, the surface charge of Du-CDs is 9.2 ± 0.6 mV, indicating that Du-CDs have supercationic properties.

[0055] 4. UV-visible absorption spectrum detection of Du-CDs

[0056] The UV-visible absorption spectrum of Du-CDs prepared in Example 1 in ultrapure water was measured by UV-visible spectrophotometer (UV-2600, Shimadzu, Japan). Figure 3 As shown, there is an absorption peak at around 280 nm, which is due to the π-π* transition of the C=C or C=O bond.

[0057] 5. Fluorescence spectroscopy detection of Du-CDs

[0058] The fluorescence spectrum of Du-CDs prepared in Example 1 in water was measured by fluorescence spectrophotometer (RF-5301PC, Shimadzu, Japan). Figure 4 As shown in Figure 2, the fluorescence emission spectrum of Du-CDs has the strongest fluorescence at 390 nm, and the excitation wavelength is 316 nm. Figure 4 The middle peak corresponds to a position of about 400 nm, proving that Du-CDs are blue. The above experiments effectively prove that the Du-CDs blue fluorescent carbon dots of the present invention are successfully synthesized.

[0059] Example 3

[0060] Antibacterial evaluation of Du-CDs

[0061] Wild-type Staphylococcus aureus, Escherichia coli, and Candida albicans were used as model strains of Gram-positive bacteria, Gram-negative bacteria, and fungi, respectively. Each strain was cultured to the logarithmic phase, washed with 0.9% sodium chloride solution, and diluted to a final concentration of 1×10 6CFU / mL. The diluted microbial cells were inoculated into a 96-well plate, and the final concentration of 50 μg / mL fungal ethyl acetate extract (raw material) or 50 μg / mL Du-CDs prepared in Example 1 was added, and the bacterial solution without any material was used as a control. The cells were incubated at 37°C (bacteria) or 28°C (fungi) in a shaker at 180 rpm for 1 hour to compare their antibacterial activities. Figure 5 As shown, the cell viabilities of Staphylococcus aureus, Escherichia coli, and Candida albicans treated with the ethyl acetate extract of the fungus were 34.5%, 37.2%, and 39.9%, respectively, while those treated with Du-CDs were significantly reduced to 7.2%, 8.1%, and 4.3%, indicating that Du-CDs exhibited significantly enhanced antibacterial activity compared to the raw extract.

[0062] Example 4

[0063] Concentration-dependent antibacterial evaluation of Du-CDs

[0064] The concentration was 1×10 6 CFU / mL suspensions of Staphylococcus aureus, Escherichia coli, and Candida albicans were inoculated into 96-well plates and treated with different concentrations of Du-CDs prepared in Example 1. Bacteria were cultured at 37°C and 160 rpm for 24 h, and fungi were cultured at 28°C and 160 rpm for 24 h. The OD values ​​of the bacterial suspensions were recorded. 600 The value changes over time. Figure 6 As shown, when the concentration of Du-CDs reached 10, 50 and 50 μg / mL, respectively, the cell growth of Staphylococcus aureus, Escherichia coli and Candida albicans was completely inhibited.

[0065] Example 5

[0066] Evaluation of the broad-spectrum antibacterial activity of Du-CDs

[0067] 1×10 6 Bacteria / fungi cultured at different CFU / mL in the presence of Du-CDs at 37°C (bacteria) or 28°C (fungi) in a shaker at 180 rpm for 24 hours were incubated. The lowest CDs concentration that resulted in no turbidity was defined as the MIC of the CDs against that bacterium / fungus. As shown in Table 1, the MICs of Du-CDs for both Gram-positive and Gram-negative strains did not exceed 4 μg / mL, while those for Candida albicans and Saccharomyces cerevisiae were higher, at 18 μg / mL and 24 μg / mL, respectively. These results demonstrate the broad-spectrum antimicrobial activity of Du-CDs.

[0068] Table 1 Evaluation of the broad-spectrum antibacterial activity of Du-CDs

[0069]

[0070] Example 6

[0071] In vivo antibacterial effect and wound healing evaluation of Du-CDs

[0072] The dorsal hair of 3-4 week old Balb / c mice was removed and a full-thickness wound with a diameter of 10 mm was made with scissors. 8 A suspension of 100 cells of Staphylococcus aureus was inoculated into the wound. The experimental mice were divided into two groups, and five mice in each group were treated with PBS (pH 7.4, control group) and 2 mg / mL of Du-CDs prepared in Example 1, respectively. Starting from 24 hours after infection, 20 μL of solution was added to the wound every 3 days for 21 days. The wound size and weight of the mice were measured every day. Every 3 days, bacteria in the wound tissue were collected with a PBS cotton swab and diluted on LB agar, and the colony count was used to determine the severity of the infection. Figure 7 As shown, after day 3, the wound area reduction in the Du-CDs group was significantly greater than that in the control group. The wounds in the Du-CDs group were completely healed by day 18, and those in the PBS group were completely healed by day 21. The number of residual Staphylococcus aureus in the Du-CDs-treated wounds was significantly lower than that in the PBS-treated wounds. Furthermore, the body weight of all tested mice gradually increased, with no significant difference between the Du-CDs and PBS groups. Macroscopically, this demonstrates the good biosafety of Du-CDs. These results demonstrate that Du-CDs can significantly accelerate skin wound closure, enhance antimicrobial activity, and maintain good biosafety.

[0073] Example 7

[0074] Evaluation of hemolytic activity of Du-CDs

[0075] Fresh red blood cells (RBCs) were extracted from whole blood of healthy mice by centrifugation at 5000 rpm for 5 minutes, washed three times, and resuspended in PBS. The isolated red blood cells were incubated with Du-CDs prepared in Example 1 at final concentrations of 1, 2, 5, 10, and 15 μg / mL at 37°C for 1 hour, followed by centrifugation at 5000 rpm for 5 minutes. The supernatant was transferred to a 96-well plate, and its absorbance at 405 nm was measured to calculate the hemolysis rate. Red blood cells treated with PBS and deionized water were set as negative and positive controls, respectively. Figure 8 As shown, after incubation with 15 μg / mL Du-CDs for 1 h, only 13.14% of red blood cells were lysed, indicating that Du-CDs has good blood compatibility.

Claims

1. An antibacterial blue fluorescent carbon dot derived from fungi, characterized in that: The carbon dots are made from the extract of Aspergillus niger and are heated to synthesize fluorescent carbon dots.

2. The fungus-derived antibacterial blue fluorescent carbon dots according to claim 1, characterized in that: The Diaporthe unshiuensis is Diaporthe unshiuensis YSP3.

3. The fungus-derived antibacterial blue fluorescent carbon dots according to claim 1, characterized in that: The extract is an ethyl acetate extract.

4. A method for preparing antibacterial blue fluorescent carbon dots derived from fungi, characterized in that: The steps include: (1) culturing the strain Aspergillus intermedius to obtain mycelium; (2) transferring the mycelium to potato glucose medium for further cultivation; (3) filtering the culture solution and extracting it with ethyl acetate to obtain an extract; (4) heating the extract to obtain a solvent-free substance; (5) The solvent-free substance was dissolved in deionized water and centrifuged to obtain an aqueous solution containing Du-CDs, which was dialyzed and freeze-dried to obtain blue carbon dots.

5. The method for preparing antibacterial blue fluorescent carbon dots derived from fungi according to claim 4, characterized in that: The culture conditions in step (1) are 25-30° C. for 3-7 days; and the culture conditions in step (2) are 20-30° C. for 1-5 days.

6. The method for preparing antibacterial blue fluorescent carbon dots derived from fungi according to claim 4, characterized in that: In step (3), the culture solution is filtered through filter paper and then extracted 2-3 times with an equal volume of ethyl acetate.

7. The method for preparing antibacterial blue fluorescent carbon dots derived from fungi according to claim 4, characterized in that: In step (4), the extract is transferred to a stainless steel autoclave and heated at 120-240° C. for 6-18 hours to obtain a solvent-free substance.

8. Use of the fungus-derived antibacterial blue fluorescent carbon dots according to claim 1 in the preparation of in vivo and in vitro antibacterial drugs or reagents.

9. The use according to claim 8, characterized in that: The antibacterial microorganisms include Gram-positive bacteria, Gram-negative bacteria and fungi; the Gram-positive bacteria include Escherichia coli, Proteus, and Serratia marcescens; the Gram-negative bacteria include Staphylococcus aureus, Staphylococcus epidermidis, and Micrococcus luteus; the fungi include Saccharomyces cerevisiae and Candida albicans.

10. Use of the fungus-derived antibacterial blue fluorescent carbon dots according to claim 1 in the preparation of a medicine having wound healing ability.

Citation Information

Patent Citations

  • Preparation method and application of fungal hypha nitrogen and sulfur self-doped carbon dots

    CN109593523A

  • Lactobacillus-derived carbon quantum dot and preparation method thereof

    CN109722242A

  • Blue light-emitting antibacterial carbon dots as well as preparation method and application thereof

    CN111944524A

  • Fluorescent antibacterial carbon dot as well as preparation method and application thereof

    CN112494517A

  • Photosynthetic bacterium red-light carbon dot as well as preparation method and application thereof

    CN113372907A